BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27254881)

  • 1. [Squamous Cell Carcinoma and Basal Cell Carcinoma--The Frontline for Pathophysiology. Diagnosis and Therapy].
    Kadono T
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):425-8. PubMed ID: 27254881
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
    Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
    Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
    [No Abstract]   [Full Text] [Related]  

  • 4. Hip to the Game: YAP/TAZ is required for nonmelanoma skin cancers.
    Miranda MM; Lowry WE
    EMBO J; 2018 Sep; 37(17):. PubMed ID: 30037822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apoptosis in basal cell and squamous cell carcinoma formation.
    Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
    Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness.
    Matas-Nadal C; Gatius S; Ribes-Santolaria M; Guasch-Vallés M; Gomez Arbones X; Casanova JM; Aguayo-Ortiz RS; Garí E
    Arch Dermatol Res; 2024 Jun; 316(7):342. PubMed ID: 38847933
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract]   [Full Text] [Related]  

  • 8. Capitalizing on mechanisms of skin cancer development?
    Bard S; Kirsner RS
    J Invest Dermatol; 2011 Aug; 131(8):1592. PubMed ID: 21753761
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part I.
    Walls B; Jordan L; Diaz L; Miller R
    J Drugs Dermatol; 2014 Aug; 13(8):947-52. PubMed ID: 25116973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part II.
    Walls B; Jordan L; Diaz L; Miller R
    J Drugs Dermatol; 2014 Aug; 13(8):955-8. PubMed ID: 25116974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of various keratins in basal cell, metastatic, and squamous cell skin cancer].
    Kazantseva IA; Khlebnikova AN; Babaev VR
    Biull Eksp Biol Med; 1994 Sep; 118(9):300-3. PubMed ID: 7529596
    [No Abstract]   [Full Text] [Related]  

  • 13. Basal cell and squamous cell carcinoma of the skin.
    Clabaugh WA
    Am Fam Physician; 1973 May; 7(5):78-86. PubMed ID: 4701036
    [No Abstract]   [Full Text] [Related]  

  • 14. [Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
    Hafner C
    Hautarzt; 2010 Apr; 61(4):356-8. PubMed ID: 20309511
    [No Abstract]   [Full Text] [Related]  

  • 15. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
    Walls B
    Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib.
    Iarrobino A; Messina JL; Kudchadkar R; Sondak VK
    J Am Acad Dermatol; 2013 Jul; 69(1):e33-4. PubMed ID: 23768306
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer.
    Zemtsov A
    Arch Dermatol Res; 2010 Apr; 302(3):169-70. PubMed ID: 19902230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous basal cell carcinoma with dual differentiation into squamous cell carcinoma and spindle cell squamous cell carcinoma: a case report with immunohistochemical studies.
    Terada T
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):130-2. PubMed ID: 23227812
    [No Abstract]   [Full Text] [Related]  

  • 19. Concordance of genetic changes in basal cell carcinoma and associated clusters of squamous cells.
    Böni R; Vortmeyer AO; Stern JB; Burg G; Hofbauer G; Zhuang Z
    J Invest Dermatol; 1998 Jul; 111(1):173-4. PubMed ID: 9665407
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinct protein expression and activity of transglutaminases found in different epidermal tumors.
    Karashima T; Furumura M; Ishii N; Ohyama B; Saruta H; Natsuaki Y; Nakama T; Ohata C; Tsuruta D; Hitomi K; Hashimoto T
    Exp Dermatol; 2014 Jun; 23(6):433-5. PubMed ID: 24750515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.